Pathologic lymphovascular invasion (LVI) has been proven to be related to tumor recurrence in lung adenocarcinoma (ADC). proportional hazard analysis for clinical and pathological predictive factors for tumor recurrence are shown in Table ?Table1.1. 51803-78-2 manufacture Tumor recurrence was observed in 34 (2.4%) of the 275 patients, with local recurrence in 6 patients and distant… Continue reading Pathologic lymphovascular invasion (LVI) has been proven to be related to